Muscular Side Effects of Statins
- 1 August 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 40 (2) , 163-171
- https://doi.org/10.1097/00005344-200208000-00001
Abstract
Lipid lowering has been shown to be effective in preventing primary and recurrent cardiovascular events and to save life. Statins almost exclusively used for this purpose meanwhile became one of the most widely prescribed families of drugs world-wide. Myopathies – mainly not well characterized – are the major group of side effects. We here review different types of clinical appearances, localizations, symptoms and the biochemical background. The data indicate that severe muscular side effects are rare. Patients and their doctors, however, easily overlook mild ones. Myopathic symptoms without any known biochemical correlate are not rare. No general guideline exists about exact diagnosis and differential diagnosis. Strict adherence to the measures of life-style change and performance of regular exercise can even further enhance significantly these side effects. Much more research should be directed onto the pathophysiological (genetic?) background to finally evaluate possible therapeutic consequences rather than simply to withdraw or change the respective statin.Keywords
This publication has 42 references indexed in Scilit:
- Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up StudyEpidemiology, 2001
- Increased lipid peroxidation in a patient with CK-elevation and muscle pain during statin therapyAtherosclerosis, 2000
- Evaluation of skeletal muscle metabolism and response to erythropoietin treatment in patients with chronic renal failure using 99Tcm-sestamibi leg scintigraphyNuclear Medicine Communications, 2000
- CorrespondenceAtherosclerosis, 2000
- Lowering LDL CholesterolCirculation, 1999
- Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyArchives of internal medicine (1960), 1996
- Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionMetabolism, 1995
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaArchives of internal medicine (1960), 1991
- Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipientsJAMA, 1988